Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.
Saved in:
| Title: | Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. |
|---|---|
| Authors: | Geethadevi A; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA., Tsaih SW; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Parashar D; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.; Department of Medicine, Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Kadamberi IP; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA., Deng H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA., George J; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Kumar S; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Mittal S; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA., Pradeep S; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.; Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA. Zhiqiang.An@uth.tmc.edu., Chaluvally-Raghavan P; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu.; Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 Jun 05; Vol. 8 (1), pp. 127. Date of Electronic Publication: 2024 Jun 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38839865 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Geethadevi+A%22">Geethadevi A</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Ku+Z%22">Ku Z</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tsaih+SW%22">Tsaih SW</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Parashar+D%22">Parashar D</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.; Department of Medicine, Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Kadamberi+IP%22">Kadamberi IP</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Xiong+W%22">Xiong W</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Deng+H%22">Deng H</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22George+J%22">George J</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Mittal+S%22">Mittal S</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+N%22">Zhang N</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pradeep+S%22">Pradeep S</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.; Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22An+Z%22">An Z</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA. Zhiqiang.An@uth.tmc.edu.<br /><searchLink fieldCode="AU" term="%22Chaluvally-Raghavan+P%22">Chaluvally-Raghavan P</searchLink>; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu.; Medical College of Wisconsin Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu.; Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA. pchaluvally@mcw.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2024 Jun 05; Vol. 8 (1), pp. 127. <i>Date of Electronic Publication: </i>2024 Jun 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38839865 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-024-00593-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127 Titles: – TitleFull: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Geethadevi A – PersonEntity: Name: NameFull: Ku Z – PersonEntity: Name: NameFull: Tsaih SW – PersonEntity: Name: NameFull: Parashar D – PersonEntity: Name: NameFull: Kadamberi IP – PersonEntity: Name: NameFull: Xiong W – PersonEntity: Name: NameFull: Deng H – PersonEntity: Name: NameFull: George J – PersonEntity: Name: NameFull: Kumar S – PersonEntity: Name: NameFull: Mittal S – PersonEntity: Name: NameFull: Zhang N – PersonEntity: Name: NameFull: Pradeep S – PersonEntity: Name: NameFull: An Z – PersonEntity: Name: NameFull: Chaluvally-Raghavan P IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 06 Text: 2024 Jun 05 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 8 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |